title: Effect of estrogens on renal responsiveness to parathyroid hormone in elderly female subjects.
abstract: The effect of estrogens on the renal responsiveness to parathyroid hormone (PTH) was examined by PTH loading tests with synthetic human-PTH (1-34) in 8 normal elderly females (mean +/- SD age, 81.0 +/- 7.1 yr) before and after administration of estrogen (Premarin 1.25 mg/day for 4 weeks). Basal urinary adenosine cyclic 3', 5'-monophosphate (cAMP) excretion showed a tendency to increase after estrogen administration (5.47 +/- 1.68 vs 6.60 +/- 2.67 nmol/100 ml GFR) and the theoretical renal phosphorous threshold showed a tendency to decrease from 3.22 +/- 0.98 to 2.73 +/- 0.56 mg/dl. The blood ionized calcium concentration did not change after estrogen administration (4.44 +/- 0.16 vs 4.32 +/- 0.20 mg/dl) and serum phosphorous (P) decreased significantly (3.65 +/- 0.47 vs 3.01 +/- 0.42 mg/dl, p less than 0.05). There was no increase in mean serum immunoreactive PTH (0.34 +/- 0.10 vs 0.34 +/- 0.05 ngeq/ml). The urinary excretions of cAMP in response to PTH loading [100 U of human-PTH (1-34), intravenously] significantly (p less than 0.05) increased (94.8 +/- 57.0 vs 196.7 +/- 118.3 nmol/100 ml GFR/h) after estrogen administration. Moreover the changes in urinary excretion of cAMP (r = 0.698, p less than 0.01) and P (r = 0.555, p less than 0.05) induced by the PTH loading were positively correlated with serum estradiol in elderly females, assessed as groups before and after estrogen administration. These results suggest that estrogens may enhance the renal responsiveness to exogenous PTH administration.
authors.affiliation: Department of Medicine and Geriatrics, Osaka University Medical School, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Imanaka
authors.forename: S
authors.initials: S
authors.lastname: Morimoto
authors.forename: T
authors.initials: T
authors.lastname: Onishi
authors.forename: S
authors.initials: S
authors.lastname: Takamoto
authors.forename: K
authors.initials: K
authors.lastname: Fukuo
authors.forename: E
authors.initials: E
authors.lastname: Koh
authors.forename: K
authors.initials: K
authors.lastname: Itoh
authors.forename: T
authors.initials: T
authors.lastname: Hironaka
authors.forename: T
authors.initials: T
authors.lastname: Shiraishi
authors.forename: R
authors.initials: R
authors.lastname: Morita
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002118:Calcium / Q000032:analysis / Q000097:blood / Q000652:urine; D000242:Cyclic AMP / Q000652:urine; D004958:Estradiol / Q000097:blood; D004967:Estrogens / Q000494:pharmacology*; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D006801:Humans; D007668:Kidney / Q000378:metabolism*; D007986:Luteinizing Hormone / Q000097:blood; D010281:Parathyroid Hormone / Q000494:pharmacology*; D010758:Phosphorus / Q000652:urine; D012709:Serum Albumin / Q000032:analysis
chemical_list: D004967:Estrogens; D010281:Parathyroid Hormone; D012709:Serum Albumin; D010758:Phosphorus; D004958:Estradiol; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D000242:Cyclic AMP; D002118:Calcium